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ABSTRACT
This work describes for first time the fabrication and characterization of multicomponent
interpenetrating networks composed of collagen I, hyaluronic acid, and poly(ethylene glycol) diacrylate
for the 3D culture of human neural stem cells, astrocytes, and microglia. The chemical composition of the
scaffolds can be modulated while maintaining values of complex moduli within the range of the
mechanical performance of brain tissue (≈ 6.9kPa) and having cell viability exceeding 84%. The
developed scaffolds are a promising new family of biomaterials that can potentially serve as 3D in vitro
models for studying the physiology and physiopathology of the central nervous system.

Neurons, astrocytes, and microglia are three of the main cell types present in the central nervous
system (CNS). They are the central focus of attention in the study of CNS physiology and the development
of neurological pathologies including Alzheimers’ disease (AD), Parkinson’s disease (PD) and
amyotrophic lateral sclerosis (ALS) among others

1-5

. Numerous in vitro neuronal models rely upon the

culture of these cells on plastic or glass-based surfaces. These 2D platforms, however, are poor
representations of the natural cell milieu since they fail to recapitulate key aspects of the 3D microarchitecture of native tissue 6. In addition, cells in 2D models experience surfaces with rigidity values
orders of magnitude greater than the rigidity present in native tissue. Moreover, in 2D environments the
presence of diffusional limitations for the exchange of nutrients, waste products, or the accumulation of
extracellular matrix (ECM) components is either restricted or nonexistent 7. This drawback directly
restrains studies focused on the production and accumulation of amyloid beta or tau proteins, both of
which are the most recognized ECM indicators of AD progression 8-9. In short, cellular responses procured
from 2D platforms cannot be directly extrapolated into 3D contexts 10. Therefore, there is still a need for
the development of novel scaffolds with the capacity to support the 3D culture of human CNS cells.
Ideally, 3D scaffolds should have the capacity to be fine-tuned to recapitulate similar chemical and
mechanical properties to those of central nervous tissue.

Multicomponent interpenetrating networks (mIPNs) offer a promising alternative to these
demands as they have the potential to present mechanically compliant scaffolds whose high water content
and chemical composition resembles soft tissue 11. While numerous approaches have been taken to utilize
mIPN hydrogels to address the demand for biocompatible 3D neural scaffolds, only a few studies have
tailored their biomaterials towards multiple neural cell types

12-13

. In this work, our team developed,

characterized and evaluated a new family of mIPNs as potential 3D scaffolds for the culture of human
CNS cells. Since obtaining neurons in high numbers is challenging, we used neural stem cells as one of

our cell models. These cells have the capacity to differentiate into neuron-like cells in large quantities 6,
14

. Neural stem cells (Human iPSC-Derived Neural Stem Cells, iHNSCs) were commercially obtained

from Cell Applications and used at passage four. In addition to neural stem cells, we also utilized human
astrocytes (HAf, Cell Applications) at passage five, and the human microglia cell line (HMC3, ATCC) as
our cell models. The three cell types were cultured and expanded in vitro following the general
recommendation and culture protocols provided by the seller. The proposed bioinspired mIPNs were
fabricated using collagen type I (Col I, BD Biosciences), hyaluronic acid (HA, Lifecore Biomedical, 1,300
kDa) and poly(ethylene glycol) diacrylate (PEGDA, Sigma) of varying molecular weights (MW).
Although these three components have been extensively utilized as hydrogel scaffolds in biomedical
applications, to the best of our knowledge, this is the first time they have been combined in a sequential
fashion to fabricate mIPN structures that support the 3D culture of three of the main cell types in the CNS.
Collagen I was selected due to its self-assembling properties, its similar chemical composition to collagen
type IV, the primary collagen type in the CNS, and because it has been previously employed in modeling
in vitro systems of brain tissue
polysaccharide in CNS tissue

15

15

. Hyaluronic acid was chosen because it is the most abundant

and because it plays an integral role in the physiology of the CNS16.

Finally, PEGDA was also employed due to its well established biocompatibility, its biological blank slate
behavior, its resistance to cell mediated contraction and degradation

17

, and because, by varying its

concentration and MW, the overall mechanical performance of the scaffolds can be fine-tuned

18-21

.

PEGDA of varying MW was synthesized following the methods described by Jimenez-Vergara et al. 18.

To fabricate the mIPNs scaffolds described in Table 1, we first assembled a semi-IPN structure
using Col I at 3.0 mg/mL and HA from 0.0 to 2.0 mg/mL. The selected values for the Col I and HA
concentrations have been previously used in other hydrogels systems

17, 22-23

. Three independent

encapsulation experiments were performed (one per cell type). In brief, undifferentiated iHNSCs, HAf or

HMC3 cells were suspended in an ice-cold Col I-HA solution (pH ≈ 7.2) at 7.5E05 cell/mL, and then 300
μL of the cell suspension were placed in 12-well plate inserts and allowed to crosslink at 37 ⁰C. At neutral
pH and 37 ⁰C, Col I molecules self-assemble into fiber structures physically entrapping the HA molecules
24-25

. Since both Col I and HA are susceptible to cell mediated contraction and degradation, PEGDA was

introduced by sequential infiltration following the methods described by Munoz-Pinto et al. to increase
the mechanical and physical stability of the scaffolds 17. In brief, 1.7 mL of PEGDA solution at 8.24%,
8.82%, or 9.41% w/w containing HA at the same target hydrogel concentration (0.0, 1.0 or 2.0 mg/mL),
and 1.0 mM Lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) as photoinitiator were placed in
contact with the initial Col I-HA hydrogels. The LAP photoinitiator was synthesized following the
methods described by Fairbanks et al.26. The addition and presence of HA in the infiltration solution
prevents the release of the physically entangled HA molecules during the infiltration of the PEGDA. Once
the infiltration step is completed, the PEGDA concentration in the hydrogel reaches 7.0%, 7.5% or 8.0%
w/w as the result of the contact between the 300 uL Col I-HA hydrogel and the 1.7 mL of the infiltrating
solution. Following the infiltration time, the excess of PEGDA solution was removed and the scaffolds
exposed to long wave UV light (365 nm, Spectroline transilluminator) for 5 min. Once the mIPN
fabrication was completed the constructs were placed in cell culture media. The required infiltration time
was estimated by tracking the changes in the complex modulus of the mIPNs. The mechanical
characterization of the scaffolds was performed 24 h after the mIPN fabrication in the absence of cells.
The measurements of the complex modulus served as an indirect method to assess the equilibrium for the
infiltration of PEGDA molecules. The mIPN7 was selected as a model for this assessment because this
formulation contains the highest levels of HA and therefore the highest resistance to diffusion among the
testing group. The complex modulus was measured using a TA Instruments Electroforce 3100 mechanical
tester. Eight millimeter diameter disks with approximate 1 mm in height were preloaded with a 2 g force,
indented 100 µm, and with an oscillation amplitude of 100 µm. All statistical analyses of the experimental

results in this work were performed using analysis of variance (ANOVA) with the Tukey’s post hoc test.
Significant differences between groups were identified and highlighted for p ≤ 0.05 (IBM SPSS software).
Figure 1 shows the changes in complex modulus of the mIPN7 as a function of the infiltration time. The
values for the complex modulus of the scaffold varied between 1.6 ± 0.3 kPa for the Col-I-HA scaffold
and 5.0 ± 1.0 kPa for scaffolds incubated with PEGDA for four hours. The increase in the complex
modulus served as an indirect measurement of the progressive infiltration of PEGDA within the Col IHA network. Scaffolds infiltrated with the PEGDA solution for 4 h of infiltration exhibited significant
differences when compared with the Col I-HA hydrogel and the 1 h group (p ≤ 0.02, n = 4), but not when
compared with the 2 h group (p = 0.724, n = 4). The steady state behavior of the complex modulus of the
mIPN after 2 h infiltration suggests that 4 h can be assumed as the equilibrium time of the system. Since
cells are exposed to soluble PEGDA and HA molecules during the infiltration of the initial CoI-HA
network, extending the infiltration time beyond the 4 h time point may result in a reduction in the
cytocompatibility of the scaffolds. Therefore we selected 4 h as the infiltration time for the fabrication
process of the mIPNs.

To gain insight into the microscopic structure of the proposed mIPNs, we performed scanning
electron microscopy (SEM) using a JEOL JSM-6010LA Scanning Electron Microscope on the mIPN7
which contains 3.0 mg/mL Col I, 2.0 mg/mL HA and 7.0% w/w 3.4 kDa PEGDA. Appropriate controls
including a pure Col I, pure PEGDA, and Col I-PEGDA hydrogels were also imaged. The mIPN7 and the
controls were fabricated and allowed to swell for 24 h, the specimens were prepared for imaging following
a modified protocol from Raub et al.

22

. In brief, the hydrogel specimens were fixed with 10.0% v/v

formalin and dehydrated using ethanol and hexamethyldisilazane. Following the dehydration procedure
the samples were cut into two pieces and allowed to dry for 24 h. The samples were then stored until use
in a desiccator. Prior to imaging, specimens were mounted on SEM sample stages using carbon tape and

sputter coated with gold to a thickness of 6 nm using a Cressington 208auto sputter coater. SEM
micrographs (n = 5) were taken from the cross-sectional area of each specimen at 5.0 kV and 7,000x
magnification. Representative micrograph images are shown in Figure 2. The microscopic landscape of
the mIPN (Figure 2D) displayed increasing packing when compared to the Col I-PEGDA, the pure Col I
or PEGDA hydrogels (Figure 2C, 2A and 2B) controls. The resulting mIPN microenvironment differs
significantly from the pure Col I network which displays the characteristic fiber structures (Figure 2A),
and the pure PEGDA network characterized by a dense mesh-like architecture. The addition of HA to the
double Col I-PEGDA networks appears to increase packing density of the scaffold.

The presence of Col I and HA was qualitatively confirmed after 14 days using Picrosirius Red
(PR, Polysciences) and Alcian Blue (AB, Acros Organics) staining respectively (Figure 3). The 14 day
time point has been previously used to evaluate the integrity of similar IPN systems17. As expected, the
red coloration in the hydrogels was observed in the formulation containing Col I and not significantly
detected in the pure PEGDA hydrogel. In addition, the intensity of the blue color increased as the HA
content increased in the hydrogels from the 0.0 mg/mL HA in the PEGDA and mIPN2 to the 2.0 mg/mL
HA in the mIPN7. Furthermore, using visible absorbance spectroscopy, following a modified approach
from Frazier et al. 27, the HA levels in the mIPN7 were also quantitatively evaluated confirming a total
HA concentration of approximately 2.1 ± 0.2 mg/mL (n = 3). In brief, HA standards and mIPN7 hydrogel
samples were digested in 0.1 N NaOH and 37 °C for 72 h. A volume of 100 μL of the digested samples
or standards solutions were placed in contact with a 1.0 mg/mL AB in 3.0% v/v acetic acid solution. The
resulting mixture was incubated at room temperature for 30 min, and then centrifuged at 10,000 rpm for
5 min. The supernatant was removed and the pellet dissolved in 400 μL of the Blyscan dissociation reagent
(Accurate Chemical). The absorbance of each sample and standard was read at 680 nm using a
SpectraMax M4 multi-mode microplate reader. The concentration of HA in the samples was calculated

by interpolating the absorbance reading in the standard curve. Cumulatively, the microscopic
characterization, the staining, and the spectroscopy confirmed the presence of the three network
components in the mIPNs.

In terms of mechanical performance, the complex modulus of the mIPN formulations shown in
Table 1 was evaluated and compared with the viscoelastic properties of the cortex of mouse brain (MB).
Tissue samples were donated by Dr. James Roberts’ laboratory. Cerebral cortex samples were collected
from mice in accordance with general NIH guidelines for the use and care of animals in research and the
approval of the Trinity University Animal Care and Use Committee (IACUC). Figures 4A-4C show the
complex moduli of mIPNs with different HA content: 0.0, 1.0, and 2.0 mg/mL respectively. As expected,
the incorporation of PEGDA dominates the mechanical behavior of the scaffolds. By either increasing the
MW of PEGDA, or by reducing its concentration, the resulting scaffolds exhibited a reduction in their
complex modulus. This observation is in agreement with previously reported literature 17-19, 28. In Figure
4A, the complex modulus of the mIPN containing 20.0 kDa PEGDA (mIPN1) was 4.2 kPa while the
mIPN2 (10.0 kDa PEGDA) exhibited a modulus of 7.4 kPa. The modulus of the mIPN1 was significantly
lower than the modulus in the MB tissue or the mIPN2 (p ≤ 0.028). The mechanical performance of the
mIPN3, mIPN4, and mIPN5 is shown in Figure 4B. These formulations which contain 1.0 mg/mL HA
and 7.0 to 8.0% w/w PEGDA 3.4 kDa or 6.0 kDa did not exhibit significant differences in terms of
complex modulus when compared to MB tissue (p ≥ 0.247). The complex modulus of scaffolds containing
HA at 2.0 mg/mL and 3.4 kDa PEGDA at 7.0 to 8.0% w/w is presented in Figure 4C. In this series mIPN,
formulations containing 3.4 kDa PEGDA levels at 8.0% w/w or higher concentration displayed
significantly higher values of complex modulus when compared to MB tissue (p = 0.003). Finally, Figure
4D summarizes the mechanical performance of three mIPN formulations exhibiting similar complex
modulus to that measured in MB (≈ 6.9 kPa), while allowing the modulation of the HA content from 0.0

to 2.0 mg/mL. These findings are very significant since, by modulating the MW and concentration of
PEGDA, the mechanical properties of the mIPNs can be adjusted to mimic the modulus of brain tissue
while the content of biochemical cues such as HA can be varied. Differences in the biochemical content
in the mIPNs can then be used to study processes such as tissue degradation or tissue scarring.

Thus far, we have demonstrated that the chemical composition of the bioinspired mIPNs can be
modulated to achieve a family of materials exhibiting complex moduli within a relevant range of values
of CNS tissue. While the presence of Col I and HA provides biochemical cues, PEGDA was introduced
to maintain mechanical stability and to limit cell-mediated contraction and degradation 17. Our final goal
was to highlight that our fabrication procedure resulted in a cytocompatible system that supports the 3D
in vitro culture of human neural stem cell, astrocytes and microglia. Toward this end, the Live/Dead
viability assay (Invitrogen) was performed 24 h post cell encapsulation in the mIPN7 formulation as
shown in Figure 5. At least four regions from four independent specimens were imaged using a laser
Nikon A1 confocal microscope system. Cell counts were obtained using Image J and the viability reported
as the ratio between living cells and the total number of cells (Figure 5A). Representative images of the
cell viability assay are reported in Figure 5B. Cell viability for iHNSCs, HAf, and HMC3 24 h post
scaffold fabrication was 84%, 93%, and 89% respectively. The viability of the iHNSCs was the lowest
among the three evaluated cell types. This observation can be explained if we consider that stem cells are
more sensitive than non-stem cells, and that they require very specific substrates and cell culture
conditions for their growth and maintenance. The viability of the scaffolds could be further enhanced by
introducing additional ECM components such as laminin or laminin-based peptide sequences

29

. The

overall viability results demonstrated that the mIPNs are very promising scaffolds which can sustain at
least 84% cell viability. These results are within the range of values previously reported for hydrogel
based systems30.

Cumulatively, we have demonstrated that in the proposed family of mIPNs the chemical
composition can be adjusted to achieve complex moduli within the range of mechanical properties of CNS
tissue. The SEM characterization, PR and AB staining, and absorbance spectroscopy confirmed the
incorporation of the three components. Finally, encapsulated human astrocytes, microglia, and neural
stem cells exhibited very good viability values which exceed 84%. We believe that this proposed platform
could potentially be used as an in vitro 3D model for studying the physiology and the progression of
pathologies associated with three of the main cells types in the CNS. In addition, we also envision that
the 3D context provided by the mIPNs could potentially aid in understanding some of the molecular
mechanisms responsible for the production and accumulation of ECM components, such as amyloid beta
and the tau protein, and their effects on the behavior of neuron-like cells, astrocytes, and microglia.
Moreover, since the presence of Col I has been associated with astrocyte reactivity and HA with the
promotion of quiescent astrocytes 23, the fine tuning of the Col I-HA ratio in the scaffolds could be used
to study glial scar formation. Therefore, our mIPNs offer the opportunity to study the astrocyte reactivity
that is characteristic of the brain inflammation preceding and during AD neurodegeneration. In summary,
the continuous development of these novel scaffolds will be of great interest to the neuroscience and the
Alzheimer’s research community.
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Graphical Abstract.

Figure 1. Effects of infiltration time on mIPN complex modulus. *Significantly different from Col I-HA,
p < 0.05; #significantly different from 1 h infiltration time, p < 0.05, n = 4.

Figure 2. Representative SEM micrographs of scaffold microstructures. (A) Pure Col I. (B) Pure 3.4 kDa
PEGDA. (C) Col I-PEGDA scaffold. (D) Col I-HA-PEGDA mIPN7. Images were taken at 7,000x
magnification, scale bar = 1μm, n = 5.

Figure 3. Representative images of Picrosirius Red (PR) and Alcian Blue (AB) staining of pure 3.4 kDa
PEGDA, Col I, mPIN2 (0.0 mg/mL HA) and mIPN7 (2.0 mg/mL HA).

Figure 4. Effects of composition on mIPN complex modulus. (A) mIPNs containing 0.0 mg/mL HA. (B)
mIPNs containing 1.0 mg/mL HA. (C) mIPNs containing 2.0 mg/mL. (D) Selected mIPNs of varying
composition displaying values of complex modulus similar to that in mouse brain tissue. Data are reported
as average plus or minus the standard deviation; *, significantly different from mouse brain, p < 0.05; #,
significantly different from mIPN1, p < 0.05; &, significantly different from mIPN6, p < 0.05; $,
significantly different from mIPN7; the absence of marks over the experimental groups indicates that
differences among them are not statistically significant (p ≥ 0.05), n = 5.

Figure 5. Cell viability of iHNSC, HAf, and HMC3 after 1 day of culture in mIPN7. (A) Quantitative
results using ImageJ software. (B) Representative laser scanning confocal microscopy images of
Live/Dead staining, n = 4.

Table 1. Chemical composition of mIPNs.
mIPN

mIPN1
mIPN2
mIPN3
mIPN4
mIPN5
mIPN6
mIPN7
mIPN8

Collagen
concentration
(mg/mL)
3.0
3.0
3.0
3.0
3.0
3.0
3.0
3.0

HA
concentration
(mg/mL)
0.0
0.0
1.0
1.0
1.0
2.0
2.0
2.0

PEGDA
molecular
weight (kDa)
20.0
10.0
6.0
6.0
3.4
3.4
3.4
3.4

PEGDA
concentration
(%w/w)
7.0
7.0
7.0
8.0
7.0
7.0
7.5
8.0

